Neutrophil-activating protein in Bacillus spores inhibits casein allergy via TLR2 signaling
NAP offers a new strategy in the treatment of CAS allergy by inhibiting the Th2 response, while eliciting macrophages to promote Th1 immune responses.
Authors
- Zhenwen Zhou (ORCID: https://orcid.org/0000-0002-0545-8729)
- Jie Liu (ORCID: https://orcid.org/0000-0001-9758-9306)
- Xiaojun Xiao (ORCID: https://orcid.org/0000-0002-1195-0541)
- Zhuwei Liang
- Zhile Xiong (ORCID: https://orcid.org/0000-0002-7843-5894)
- Bingshao Liang (ORCID: https://orcid.org/0000-0002-6613-340X)
- Jialiang Mai
- Damo Xu (ORCID: https://orcid.org/0000-0003-1192-9213)
- Pingchang Yang (ORCID: https://orcid.org/0000-0002-4857-7568)
- Kaiyue Yang
- Chao Zhang (ORCID: https://orcid.org/0000-0003-4516-8037)
- Xiaoyu Liu (ORCID: https://orcid.org/0009-0006-6681-2783)
Institutions
- Shenzhen University (CN)
- Capital Medical University (CN)
- Foshan Maternity and Child Health Care Hospital (CN)
- Shenzhen Maternity and Child Healthcare Hospital (CN)
- Guangdong Provincial Hospital of Traditional Chinese Medicine (CN)
- Beijing Chest Hospital (CN)
- State Key Laboratory of Respiratory Disease (CN)
- Shenzhen Third People’s Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-05
- DOI
- https://doi.org/10.3389/fimmu.2024.1428079
- Citations
- 3
- Primary Topic
- Food Allergy and Anaphylaxis Research
- Type
- article
- Field-Weighted Citation Impact
- 1.15
Funders
- Natural Science Foundation of Guangdong Province